Lidia
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Hospital Ramón y Cajal
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Ramón y Cajal (4)
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
-
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453
2021
-
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)
Oncology Letters, Vol. 22, Núm. 5
2004
-
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study
British Journal of Pharmacology, Vol. 141, Núm. 3, pp. 457-467